Large Scale Transition to a Dolutegravir-based First-line ART in the South: Virological Response and Impact on HIV Drug Resistance in a Real Life Context (DoReaL Study)
Clinical trial NCT05312918 · UNKNOWN
Trial details
- NCT number
- NCT05312918
- Sponsor
- ANRS, Emerging Infectious Diseases
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2022-05-01
- Primary completion
- 2023-03-01
- Enrollment
- 603
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.